Depression diagnosis and treatment in Parkinson disease.
Phase of Trial: Phase IV
Latest Information Update: 10 Jan 2012
At a glance
- Drugs Atomoxetine (Primary)
- Indications Depression; Depressive disorders; Parkinson's disease
- Focus Therapeutic Use
- 07 Jun 2009 Results presented at the 13th International Congress of Parkinson's Disease and Movement Disorders.
- 10 Mar 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 13 Oct 2006 New trial record.